Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001493152-24-031414

CEO & President acquired 377,358 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Equels Thomas K · CEO & President

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-08-12 Grant or award : show line 1 in the form +377,358 $0.27 $100,000 1,155,542 D
Loading xslF345X05/ownership.xml…